Cambridge Cognition forms scientific advisory board
21st Mar 2024 16:26
(Sharecast News) - Digital brain health solutions developer Cambridge Cognition announced the creation of a scientific advisory board on Thursday.
Read moreCambridge Cognition inks strategic partnership with ActiGraph
21st Feb 2024 12:17
(Sharecast News) - Brain health specialist Cambridge Cognition announced a strategic partnership with ActiGraph, a provider of wearable technologies tailored for clinical trials, on Wednesday.
Read moreCambridge Cognition secures 'significant contract'
11th Oct 2023 10:04
(Sharecast News) - Digital solutions group Cambridge Cognition has secured a "significant contract" for a "sizeable" later-stage clinical trial, following a competitive tender.
Read moreCambridge Cognition wins £2m cancer therapy trial contract
13th Jun 2023 14:45
(Sharecast News) - Brain health assessment specialist Cambridge Cognition has secured a £2m contract for a significant cancer therapy trial, it announced on Tuesday.
Read moreCambridge Cognition wins two contracts worth £2.1m
12th Apr 2023 14:32
(Sharecast News) - Brain health technology specialist Cambridge Cognition has won two contracts worth more than £2.1m, it announced on Wednesday.
Read moreDirector dealings: Cambridge Cognition CEO makes share purchase
6th Feb 2023 15:11
(Sharecast News) - Cambridge Cognition revealed on Monday that chief executive Matthew Stork had acquired 13,500 ordinary shares in the AIM-listed technology company.
Read moreCambridge Cognition finds local partner for China expansion
24th Nov 2022 13:30
(Sharecast News) - Brain health technology developer Cambridge Cognition announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare on Thursday.
Read moreCambridge Cognition agrees £1.7m purchase of eClinicalHealth
12th Oct 2022 13:01
(Sharecast News) - Brain health specialise Cambridge Cognition has agreed to acquire virtual clinical trial solution provider eClinicalHealth (eCH), it announced on Wednesday, for up to £1.7m.
Read moreDirector dealings: Cambridge Cognition execs invest after solid update
22nd Jul 2022 14:04
(Sharecast News) - Cambridge Cognition was among a relatively thin list of director deals on Friday afternoon, after two of its executives made share purchases.
Read moreCambridge Cognition wins phase 3 contract worth over £1m
28th Mar 2022 12:41
(Sharecast News) - Brain health technology developer Cambridge Cognition has won a contract worth just over £1m with an unnamed "top 10" pharmaceutical company, it announced on Monday, to provide digital cognitive assessments for a pivotal phase 3 autoimmune disease trial.
Read moreSunday share tips: Cambridge Cognition Holdings, FRP
27th Mar 2022 10:38
(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.
Read moreCambridge Cognition awarded contracts worth £2.1m
2nd Feb 2022 12:40
(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts worth £2.1m, it announced on Wednesday, to provide cognitive assessments, electronic diaries, and third-party hardware for two clinical trials in neurodegenerative disease.
Read moreCambridge Cognition wins contracts for two clinical trials
10th Jan 2022 12:44
(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts for two clinical trials by an unnamed "top 20" pharmaceutical company, it announced on Monday, to assess the pro-cognitive effects of a new drug in schizophrenia.
Read moreCambridge Cognition secures contract for 'sizeable' schizophrenia trial
26th Oct 2021 09:11
(Sharecast News) - Digital brain health technology company Cambridge Cognition has secured a contract for a further sizeable schizophrenia trial with an existing customer, it announced on Tuesday.
Read moreCambridge Cognition turns in 'strong financial performance' in H1
3rd Aug 2021 09:31
(Sharecast News) - Software firm Cambridge Cognition said on Tuesday that it had put on a "strong financial performance" in the six months ended 30 June, with both revenue and sales growth during the period.
Read more